163 BASAL CELL CARCINOMA SECTION 12 SKIN CANCER
163 BASAL CELL CARCINOMA SECTION 12 SKIN CANCER
163 BASAL CELL CARCINOMA SECTION 12 SKIN CANCER
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MHBD<strong>12</strong>5-<strong>163</strong>[704-711].qxd 8/15/08 11:40 AM Page 711<strong>BASAL</strong> <strong>CELL</strong> <strong>CARCINOMA</strong>PART 13DERMATOLOGY711REFERENCES1.Thissen MR, Neumann MH, Schouten LJ.A systematic review oftreatment modalities for primary basal cell carcinomas. ArchDermatol. 1999;135(10):1177–1183.2. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M.Imiquimod 5% cream for the treatment of superficial basal celcarcinoma: Results from two phase III, randomized, vehiclecontrolledstudies. J Am Acad Dermatol. 2004;50(5):722–733.3. Marcil I, Stern RS. Risk of developing a subsequent nonmelanomaskin cancer in patients with a history of nonmelanoma skin cancer:A critical review of the literature and meta-analysis. Arch Dermatol.2000;136(<strong>12</strong>):1524–1530.FIGURE <strong>163</strong>-19 Extensive sebaceous hyperplasia on the cheek of a52-year-old woman. Largest one has visible telangiectasias and couldbe mistaken for a BCC. (Courtesy of Richard P. Usatine, MD.)
Change language